A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) A61K 38/00 (2006.01) A61K 39/395 (2006.01) C12N 9/10 (2006.01) C12N 9/48 (2006.01) C12N 9/68 (2006.01) C12N 9/99 (2006.01)
Patent
CA 2293302
A method of treating a mammal, preferably a human, having atherosclerotic disease is provided. The method comprises administering to the mammal an inhibitor of Factor XIIIa which is involved in the formation of atherosclerotic lesions. Methods for identifying Factor XIIIa inhibitors are also provided.
L'invention concerne un procédé de traitement d'un mammifère, de préférence, un humain, souffrant d'une affection athérosclérotique. Ledit procédé consiste à administrer au mammifère un inhibiteur du Facteur XIIIa impliqué dans la formation de lésions athérosclérotiques. Des procédés d'identification des inhibiteurs du Facteur XIIIa sont également décrits.
Arnold Anne Romanic
Ohlstein Eliot Howard
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Use of factor xiiia inhibitors to treat atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of factor xiiia inhibitors to treat atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of factor xiiia inhibitors to treat atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1893377